— Know what they know.
Not Investment Advice

CRL NYSE

Charles River Laboratories International, Inc.
1W: -0.9% 1M: -0.6% 3M: +25.4% YTD: +43.3% 1Y: +70.2% 3Y: +48.8% 5Y: -36.7%
$290.19
+3.36 (+1.17%)
 
Weekly Expected Move ±4.9%
$261 $276 $290 $304 $319
NYSE · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 62 · $14.0B mcap · 48M float · 1.92% daily turnover · Short 62% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
40.6 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 6.9%  ·  5Y Avg: 5.7%
Cost Advantage
52
Intangibles
19
Switching Cost
34
Network Effect
40
Scale ★
73
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CRL shows a Weak competitive edge (40.6/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 6.9% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$264
Low
$313
Avg Target
$357
High
Based on 16 analysts since Aug 5, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 26Hold: 10Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$305.83
Analysts18
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-30 UBS Kevin Caliendo Initiated $357 — +20.6% $295.96
2026-09-28 Jefferies David Windley $195 $340 +145 +16.1% $292.84
2026-09-25 Deutsche Bank Justin Bowers $240 $320 +80 +9.9% $291.16
2026-09-25 RBC Capital — $282 $322 +40 +10.6% $291.11
2026-09-25 Evercore ISI — $320 $330 +10 +12.1% $294.44
2026-09-25 Robert W. Baird — $291 $334 +43 +13.4% $294.44
2026-09-25 Mizuho Securities Ann Hynes $264 $295 +31 +0.2% $294.44
2026-09-25 Barclays — $300 $330 +30 +12.1% $294.44
2026-09-17 Argus Research — $200 $330 +130 +18.1% $279.40
2026-09-11 Evercore ISI — $220 $320 +100 +15.4% $277.18
2026-08-10 Piper Sandler — Initiated $300 — +11.3% $269.64
2026-08-10 Mizuho Securities — $230 $264 +34 -1.3% $267.49
2026-08-07 Morgan Stanley — $260 $300 +40 +13.6% $264.05
2026-08-06 Robert W. Baird — $213 $291 +78 +12.4% $258.93
2026-08-06 RBC Capital — $215 $282 +67 +8.2% $260.72
2026-08-05 Barclays — $220 $300 +80 +15.1% $260.72
2026-07-13 Mizuho Securities — $192 $230 +38 -1.5% $233.41
2026-07-09 Morgan Stanley — $220 $260 +40 +16.1% $223.96
2026-07-01 BNP Paribas — Initiated $250 — +10.2% $226.79
2026-06-17 Morgan Stanley — $185 $220 +35 +19.1% $184.79
2026-05-29 CLSA — Initiated $219 — +20.8% $181.34
2026-05-08 Robert W. Baird Eric Coldwell $193 $213 +20 +21.3% $175.56
2026-05-08 Evercore ISI — $260 $220 -40 +24.8% $176.32
2026-05-08 Mizuho Securities — $175 $192 +17 +5.7% $181.68
2026-05-08 Barclays Luke Sergott $210 $220 +10 +21.1% $181.68
2026-04-14 Barclays Luke Sergott $200 $210 +10 +17.8% $178.34
2026-04-13 RBC Capital — Initiated $215 — +20.6% $178.34
2026-02-20 Mizuho Securities — $215 $175 -40 +6.6% $164.24
2026-02-19 Robert W. Baird Eric Coldwell $231 $193 -38 +22.0% $158.18
2026-02-19 Barclays Luke Sergott $215 $200 -15 +26.6% $158.00
2026-01-13 Robert W. Baird — $224 $231 +7 +4.2% $221.69
2026-01-13 Evercore ISI — $200 $260 +60 +15.5% $225.11
2026-01-09 Robert W. Baird Eric Coldwell $239 $224 -15 +2.1% $219.49
2026-01-09 Mizuho Securities Ann Hynes $200 $215 +15 -0.2% $215.51
2025-12-18 Mizuho Securities — $174 $200 +26 +2.1% $195.98
2025-12-15 Barclays — $195 $215 +20 +11.4% $192.97
2025-12-01 Morgan Stanley Kallum Titchmarsh Initiated $185 — +5.1% $176.09
2025-11-17 Argus Research — $440 $200 -240 +20.0% $166.73
2025-10-17 Mizuho Securities Ann Hynes $210 $174 -36 -0.5% $174.95
2025-10-03 Evercore ISI Elizabeth Anderson $265 $200 -65 +10.4% $181.18
2025-10-02 Barclays Luke Sergott $205 $195 -10 +14.4% $170.48
2025-09-09 Jefferies — $280 $195 -85 +23.9% $157.38
2024-10-15 Barclays Luke Sergott $230 $205 -25 +6.1% $193.14
2024-10-14 Redburn Partners Jamie Clark Initiated $151 — -21.7% $192.97
2024-09-17 Mizuho Securities Ann Hynes Initiated $210 — +1.7% $206.44
2024-08-08 Deutsche Bank Justin Bowers Initiated $240 — +19.8% $200.34
2024-07-10 Robert W. Baird Eric Coldwell Initiated $239 — +18.4% $201.85
2024-06-27 Barclays Luke Sergott Initiated $230 — +10.9% $207.35
2024-06-06 Goldman Sachs Matthew Sykes Initiated $290 — +34.2% $216.12
2024-05-09 Evercore ISI Elizabeth Anderson $300 $265 -35 +15.2% $230.09

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
Oct 02, 2026
DCF
3
ROE
1
ROA
1
D/E
1
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CRL receives an overall rating of C-. Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-08-05 C C-
2026-06-24 C- C
2026-06-16 C C-
2026-05-07 C- C
2026-02-18 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 27 Grade D
Profitability
18
Balance Sheet
31
Earnings Quality
43
Growth
32
Value
28
Momentum
35
Safety
50
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CRL scores highest in Safety (50/100) and lowest in Profitability (18/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.15
Grey Zone
Piotroski F-Score
4/9
✗ ✓ ✗ ✓ ✗ ✗ ✓ ✓ ✗
Beneish M-Score
-3.11
Unlikely Manipulator
Ohlson O-Score
-6.42
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
BB-
Score: 35.9/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: -2.44x
Accruals: -10.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CRL scores 2.15, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CRL scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CRL's score of -3.11 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CRL's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CRL receives an estimated rating of BB- (score: 35.9/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-59.96x
PEG
0.63x
P/S
3.50x
P/B
4.95x
P/FCF
28.23x
P/OCF
17.97x
EV/EBITDA
60.31x
EV/Revenue
3.32x
EV/EBIT
-171.77x
EV/FCF
35.88x
Earnings Yield
-2.28%
FCF Yield
3.54%
Shareholder Yield
3.10%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CRL currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.298
NI / EBT
×
Interest Burden
2.373
EBT / EBIT
×
EBIT Margin
-0.019
EBIT / Rev
×
Asset Turnover
0.530
Rev / Assets
×
Equity Multiplier
2.437
Assets / Equity
=
ROE
-7.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CRL's ROE of -7.7% is driven by Asset Turnover (0.530), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.30 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$290.15
Median 1Y
$295.89
5th Pctile
$143.63
95th Pctile
$614.57
Ann. Volatility
42.7%
Analyst Target
$305.83
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
James C. Foster
Chair, President, Chief Executive Officer and Director
$1,461,866 $9,138,724 $14,096,924
Birgit Girshick Corporate
Executive Vice President, Chief Operating Officer
$704,811 $2,964,471 $4,989,672
Flavia H. Pease
Corporate Executive Vice President, Chief Financial Officer
$621,915 $1,722,601 $3,811,326
Joseph LaPlume Corporate
Executive Vice President Corporate Development and Strategy
$539,000 $1,702,429 $3,058,456
William D. Barbo
Corporate Executive Vice President
$568,144 $1,522,274 $2,908,735

CEO Pay Ratio

374:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $14,096,924
Avg Employee Cost (SGA/emp): $37,719
Employees: 19,700

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
19,700
-2.0% YoY
Revenue / Employee
$203,826
Rev: $4,015,382,000
Profit / Employee
$-7,327
NI: $-144,338,000
SGA / Employee
$37,719
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 18.3% 16.8% 17.6% 17.9% 17.3% 17.6% 17.4% 16.4% 16.0% 14.4% 13.0% 12.4% 11.7% 0.3% -0.9% -2.0% -2.3% -4.4% -6.0% -7.7% -7.70%
ROA 6.5% 6.2% 6.6% 6.2% 6.0% 6.6% 6.7% 6.3% 6.3% 6.0% 5.5% 5.5% 5.3% 0.1% -0.4% -0.9% -1.1% -2.0% -2.4% -3.2% -3.16%
ROIC 8.4% 8.9% 9.4% 9.4% 9.3% 8.8% 8.6% 8.2% 8.3% 8.0% 7.4% 7.3% 6.9% 1.0% -2.3% 1.7% 1.9% 5.6% 6.5% 6.9% 6.87%
ROCE 9.6% 9.3% 9.5% 9.0% 9.1% 10.5% 10.8% 11.0% 11.4% 10.1% 9.5% 9.6% 9.3% 3.4% 2.3% 1.5% 1.4% 0.1% -0.9% -1.2% -1.21%
Gross Margin 37.6% 38.4% 36.9% 36.7% 37.4% 36.3% 36.7% 37.6% 35.2% 35.9% 34.1% 34.5% 34.6% 28.4% 32.3% 34.6% 33.7% 31.0% 28.0% 36.2% 36.19%
Operating Margin 17.4% 19.1% 16.3% 19.3% 15.3% 14.9% 16.3% 15.6% 14.8% 13.1% 12.5% 14.8% 11.6% -16.7% 7.6% 9.7% 13.3% 12.1% 12.0% 11.9% 11.94%
Net Margin 11.5% 15.2% 10.2% 11.2% 9.8% 17.0% 10.0% 9.2% 8.5% 18.5% 6.7% 8.8% 6.8% -21.5% 2.6% 5.1% 5.4% -27.8% -1.5% -0.1% -0.15%
EBITDA Margin 23.3% 26.8% 21.4% 23.0% 21.1% 32.5% 23.6% 22.8% 22.0% 31.8% 21.7% 23.2% 20.8% -8.6% 18.7% 21.4% 19.7% -19.3% 6.4% 15.0% 15.02%
FCF Margin 13.2% 15.0% 11.4% 9.2% 7.4% 7.4% 6.7% 6.9% 8.7% 8.8% 10.1% 11.9% 13.8% 12.4% 14.0% 14.4% 13.5% 12.9% 9.7% 9.3% 9.27%
OCF Margin 19.6% 21.5% 19.1% 17.8% 16.2% 15.6% 15.3% 15.0% 16.6% 16.6% 17.1% 18.4% 19.6% 18.1% 19.3% 19.5% 18.6% 18.4% 15.1% 14.6% 14.56%
ROE 3Y Avg snapshot only 0.38%
ROE 5Y Avg snapshot only 6.55%
ROA 3Y Avg snapshot only 0.45%
ROIC 3Y Avg snapshot only 3.73%
ROIC Economic snapshot only 6.74%
Cash ROA snapshot only 7.73%
Cash ROIC snapshot only 10.26%
CROIC snapshot only 6.53%
NOPAT Margin snapshot only 9.76%
Pretax Margin snapshot only -4.59%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 18.84%
SBC / Revenue snapshot only 1.64%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 59.58 49.68 33.91 26.18 22.04 23.02 20.91 22.36 21.29 25.71 32.01 24.80 24.76 916.78 -250.62 -106.87 -87.96 -69.44 -42.19 -43.87 -59.957
P/S Ratio 6.90 5.49 3.95 3.15 2.54 2.82 2.54 2.59 2.40 2.96 3.42 2.63 2.52 2.33 1.97 1.84 1.82 2.50 1.93 2.62 3.495
P/B Ratio 9.74 7.66 5.49 4.38 3.66 3.76 3.34 3.33 3.06 3.39 3.86 2.88 2.70 2.73 2.48 2.21 2.16 3.17 2.65 3.68 4.955
P/FCF 52.27 36.51 34.77 34.29 34.39 37.96 37.71 37.40 27.45 33.40 33.96 22.00 18.25 18.82 14.04 12.79 13.51 19.33 19.91 28.23 28.226
P/OCF 35.27 25.53 20.66 17.69 15.66 18.07 16.57 17.31 14.50 17.84 19.94 14.28 12.85 12.85 10.19 9.39 9.80 13.59 12.83 17.97 17.969
EV/EBITDA 31.49 27.29 19.88 17.01 14.66 14.26 12.91 13.05 12.06 14.53 16.65 13.29 12.90 20.60 19.54 18.93 18.91 31.34 36.67 60.31 60.310
EV/Revenue 7.76 6.32 4.70 4.02 3.38 3.54 3.26 3.28 3.05 3.63 4.09 3.28 3.15 2.96 2.65 2.48 2.43 3.21 2.65 3.32 3.325
EV/EBIT 45.45 40.36 29.48 25.41 22.11 20.61 18.34 18.43 17.02 20.88 24.47 19.80 19.65 54.55 71.47 101.83 109.37 1710.75 -178.98 -171.77 -171.765
EV/FCF 58.81 42.07 41.42 43.77 45.68 47.67 48.46 47.35 34.90 41.04 40.61 27.46 22.80 23.86 18.94 17.29 17.96 24.83 27.23 35.88 35.878
Earnings Yield 1.7% 2.0% 2.9% 3.8% 4.5% 4.3% 4.8% 4.5% 4.7% 3.9% 3.1% 4.0% 4.0% 0.1% -0.4% -0.9% -1.1% -1.4% -2.4% -2.3% -2.28%
FCF Yield 1.9% 2.7% 2.9% 2.9% 2.9% 2.6% 2.7% 2.7% 3.6% 3.0% 2.9% 4.5% 5.5% 5.3% 7.1% 7.8% 7.4% 5.2% 5.0% 3.5% 3.54%
PEG Ratio snapshot only 0.625
EV/OCF snapshot only 22.840
EV/Gross Profit snapshot only 10.313
Acquirers Multiple snapshot only 26.927
Shareholder Yield snapshot only 3.10%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.40 1.23 1.34 1.33 1.40 1.32 1.48 1.49 1.45 1.52 1.75 1.58 1.48 1.41 1.43 1.36 1.37 1.29 1.36 1.35 1.348
Quick Ratio 1.22 1.04 1.12 1.08 1.14 1.08 1.21 1.21 1.16 1.16 1.37 1.21 1.14 1.13 1.16 1.10 1.10 1.02 1.03 1.04 1.042
Debt/Equity 1.31 1.26 1.14 1.29 1.28 1.04 1.02 0.95 0.88 0.85 0.85 0.76 0.73 0.79 0.93 0.83 0.77 0.97 1.04 1.07 1.066
Net Debt/Equity 1.22 1.17 1.05 1.21 1.20 0.96 0.95 0.89 0.83 0.78 0.76 0.71 0.67 0.73 0.86 0.78 0.71 0.90 0.97 1.00 0.999
Debt/Assets 0.45 0.46 0.42 0.45 0.45 0.41 0.41 0.40 0.38 0.37 0.38 0.36 0.34 0.36 0.39 0.37 0.35 0.43 0.40 0.40 0.402
Debt/EBITDA 3.76 3.91 3.47 3.92 3.85 3.14 3.06 2.93 2.72 2.97 3.05 2.82 2.79 4.69 5.47 5.27 5.10 7.46 10.52 13.73 13.733
Net Debt/EBITDA 3.50 3.61 3.19 3.68 3.62 2.90 2.87 2.74 2.58 2.70 2.73 2.64 2.57 4.35 5.05 4.93 4.69 6.94 9.86 12.86 12.862
Interest Coverage 6.13 7.50 10.79 14.17 16.02 11.51 8.64 6.43 5.48 5.25 5.00 5.00 4.94 1.74 1.25 0.84 0.80 0.07 -0.56 -0.73 -0.729
Equity Multiplier 2.91 2.77 2.71 2.84 2.81 2.55 2.48 2.39 2.30 2.28 2.24 2.14 2.12 2.17 2.37 2.25 2.21 2.25 2.63 2.65 2.653
Cash Ratio snapshot only 0.169
Debt Service Coverage snapshot only 2.075
Cash to Debt snapshot only 0.063
FCF to Debt snapshot only 0.122
Defensive Interval snapshot only 414.7 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.56 0.57 0.56 0.52 0.52 0.54 0.55 0.55 0.56 0.52 0.52 0.52 0.52 0.52 0.51 0.52 0.52 0.55 0.53 0.53 0.530
Inventory Turnover 11.78 11.46 10.93 10.24 10.70 11.05 10.70 9.71 9.66 8.26 8.47 8.36 8.42 8.25 8.34 8.66 8.54 9.33 8.44 8.66 8.660
Receivables Turnover 5.56 5.62 5.55 5.30 5.28 6.68 5.51 5.40 5.37 7.50 6.08 6.07 6.09 7.63 6.09 7.35 6.34 6.59 6.39 6.33 6.327
Payables Turnover 19.04 13.76 12.84 14.34 15.32 12.44 14.96 14.98 16.85 14.02 21.16 19.42 19.46 17.58 19.48 19.51 17.84 18.63 19.37 18.90 18.897
DSO 66 65 66 69 69 55 66 68 68 49 60 60 60 48 60 50 58 55 57 58 57.7 days
DIO 31 32 33 36 34 33 34 38 38 44 43 44 43 44 44 42 43 39 43 42 42.1 days
DPO 19 27 28 25 24 29 24 24 22 26 17 19 19 21 19 19 20 20 19 19 19.3 days
Cash Conversion Cycle 77 70 71 79 79 58 76 81 84 67 86 85 84 71 85 73 80 75 82 81 80.5 days
Fixed Asset Turnover snapshot only 2.191
Operating Cycle snapshot only 99.8 days
Cash Velocity snapshot only 20.825
Capital Intensity snapshot only 1.884
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 21.3% 21.1% 19.3% 12.7% 10.4% 12.3% 12.7% 13.3% 11.5% 3.9% 0.5% -2.4% -3.7% -1.9% -2.2% -1.2% -0.9% -0.9% 0.1% -0.7% -0.74%
Net Income 31.6% 7.3% 12.6% 11.9% 10.0% 24.4% 17.5% 9.2% 8.8% -2.4% -11.6% -10.8% -13.0% -97.8% -1.1% -1.2% -1.2% -15.0% -4.9% -2.4% -2.44%
EPS 29.4% 6.2% 12.1% 12.0% 10.6% 24.8% 17.2% 8.8% 8.2% -2.9% -12.3% -11.4% -13.0% -97.8% -1.1% -1.2% -1.2% -15.6% -5.1% -2.5% -2.50%
FCF 1.3% 40.0% -14.1% -30.1% -38.1% -44.6% -33.2% -14.5% 31.8% 23.9% 50.3% 68.3% 52.1% 37.3% 36.2% 18.8% -3.0% 3.4% -30.5% -35.9% -35.94%
EBITDA 23.5% 6.7% 7.5% 2.5% 3.2% 20.2% 20.4% 20.6% 22.4% 4.7% -2.3% -4.2% -7.1% -43.7% -45.9% -47.5% -47.9% -29.3% -46.8% -58.3% -58.27%
Op. Income 32.3% 36.3% 33.1% 27.1% 20.9% 10.4% 9.0% -2.6% -1.8% -5.2% -14.1% -13.2% -18.5% -63.2% -69.4% -77.8% -73.3% 88.6% 1.7% 3.0% 2.97%
OCF Growth snapshot only -26.07%
Asset Growth snapshot only -0.38%
Equity Growth snapshot only -15.32%
Debt Growth snapshot only 8.67%
Shares Change snapshot only -1.68%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 16.9% 16.0% 15.2% 14.6% 14.3% 14.9% 14.5% 15.0% 14.3% 12.2% 10.6% 7.6% 5.8% 4.6% 3.5% 3.0% 2.1% 0.3% -0.5% -1.5% -1.45%
Revenue 5Y 16.9% 16.1% 15.4% 15.3% 15.4% 16.4% 16.5% 15.6% 14.5% 12.8% 11.6% 10.7% 9.9% 9.1% 8.1% 7.9% 7.3% 6.5% 5.8% 4.1% 4.09%
EPS 3Y 40.5% 18.1% 21.2% 25.2% 22.3% 23.3% 24.9% 20.3% 15.7% 8.8% 4.9% 2.6% 1.4% -70.2% — — — — — — —
EPS 5Y 21.1% 18.8% 19.4% 17.9% 15.8% 29.4% 29.5% 29.0% 27.1% 14.9% 12.8% 13.6% 11.5% -47.5% — — — — — — —
Net Income 3Y 42.6% 20.0% 22.7% 26.5% 23.6% 24.5% 26.1% 21.3% 16.4% 9.2% 5.4% 2.9% 1.4% -70.2% — — — — — — —
Net Income 5Y 22.8% 20.4% 20.8% 19.3% 17.1% 31.6% 30.9% 30.3% 28.3% 16.0% 13.9% 14.6% 12.3% -47.2% — — — — — — —
EBITDA 3Y 20.4% 17.4% 18.1% 18.9% 19.2% 20.5% 22.0% 20.5% 16.0% 10.3% 8.1% 5.8% 5.5% -10.8% -14.0% -15.3% -16.0% -25.3% -34.5% -40.6% -40.57%
EBITDA 5Y 19.3% 16.8% 15.7% 14.9% 13.9% 16.6% 18.2% 17.7% 17.1% 15.3% 14.1% 14.2% 14.0% 0.6% -0.8% -2.5% -5.5% -11.8% -18.3% -23.6% -23.64%
Gross Profit 3Y 18.1% 16.7% 16.1% 15.6% 15.2% 15.1% 14.6% 15.9% 14.1% 11.9% 9.2% 4.7% 3.1% -0.1% -1.5% -1.7% -2.7% -3.3% -5.1% -5.9% -5.87%
Gross Profit 5Y 16.2% 15.6% 15.0% 14.7% 14.6% 15.8% 16.1% 15.8% 14.5% 12.3% 11.0% 9.8% 8.9% 6.8% 5.5% 5.7% 4.6% 4.2% 2.6% 0.8% 0.79%
Op. Income 3Y 23.2% 21.2% 22.6% 25.5% 24.2% 22.8% 21.3% 20.2% 16.2% 12.6% 7.6% 2.4% -1.1% -27.2% -34.1% -42.8% -40.2% -13.0% -10.9% -8.6% -8.64%
Op. Income 5Y 19.9% 20.0% 19.2% 18.9% 17.5% 17.7% 18.5% 18.1% 17.3% 13.2% 11.5% 10.8% 8.9% -8.3% -14.1% -19.7% -19.3% -0.2% 0.5% -1.1% -1.14%
FCF 3Y 11.6% 20.9% 15.5% 8.0% -1.8% -4.7% -10.6% -11.4% -6.2% -1.3% -4.8% 0.2% 7.4% -1.9% 11.0% 19.6% 24.8% 20.7% 12.4% 8.6% 8.60%
FCF 5Y 14.6% 17.0% 12.3% 6.4% 4.3% 4.8% 2.1% 1.6% 2.5% 3.9% 9.1% 12.6% 13.7% 8.1% 7.9% 6.8% 4.0% 6.4% -4.0% -5.2% -5.20%
OCF 3Y 16.4% 19.9% 20.5% 17.8% 11.7% 8.8% 5.4% 3.3% 5.8% 7.8% 2.8% 3.7% 5.9% -1.2% 3.8% 6.3% 6.9% 6.0% -1.0% -2.3% -2.34%
OCF 5Y 18.5% 20.6% 18.7% 15.7% 15.0% 14.4% 12.9% 11.2% 10.4% 9.2% 12.2% 13.3% 12.6% 8.8% 7.7% 6.8% 4.9% 6.2% -1.3% -2.8% -2.84%
Assets 3Y 23.0% 22.1% 21.7% 17.6% 17.2% 17.4% 14.0% 14.0% 13.4% 14.3% 12.0% 5.8% 4.3% 2.3% 2.3% 0.1% 0.6% -2.1% 0.1% -1.0% -1.04%
Assets 5Y 21.3% 21.0% 21.3% 22.1% 20.8% 21.0% 20.7% 15.0% 14.9% 16.3% 15.7% 11.4% 11.8% 9.9% 7.8% 7.6% 7.6% 5.4% 5.9% 2.3% 2.31%
Equity 3Y 24.6% 24.4% 23.1% 22.1% 19.7% 22.1% 23.5% 22.9% 20.3% 19.4% 18.6% 17.1% 15.9% 10.9% 7.0% 8.2% 9.0% 2.1% -1.8% -4.4% -4.42%
Book Value 3Y 22.8% 22.5% 21.6% 20.8% 18.4% 20.9% 22.3% 21.9% 19.6% 18.9% 18.0% 16.7% 15.9% 11.2% 7.3% 9.6% 10.4% 3.5% -0.2% -2.5% -2.50%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.98 0.98 0.98 0.99 0.99 0.99 0.99 1.00 0.99 0.98 0.96 0.94 0.91 0.87 0.81 0.76 0.72 0.66 0.59 0.48 0.482
Earnings Stability 0.80 0.91 0.89 0.87 0.88 0.98 0.98 0.98 0.97 0.93 0.83 0.79 0.74 0.06 0.10 0.16 0.22 0.56 0.62 0.67 0.666
Margin Stability 0.97 0.98 0.98 0.97 0.98 0.98 0.99 0.98 0.99 0.99 0.98 0.97 0.97 0.95 0.94 0.94 0.94 0.94 0.93 0.93 0.927
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.87 0.97 0.95 0.95 0.96 0.90 0.93 0.96 0.96 0.99 0.95 0.96 0.95 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.500
Earnings Smoothness 0.73 0.93 0.88 0.89 0.90 0.78 0.84 0.91 0.92 0.98 0.88 0.89 0.86 0.00 — — — — — — —
ROE Trend 0.01 -0.01 0.00 0.00 0.00 0.00 -0.01 -0.02 -0.02 -0.03 -0.04 -0.04 -0.05 -0.14 -0.15 -0.15 -0.15 -0.11 -0.12 -0.13 -0.132
Gross Margin Trend 0.01 0.01 0.01 0.00 0.00 -0.00 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.04 -0.04 -0.03 -0.03 -0.02 -0.02 -0.01 -0.015
FCF Margin Trend -0.01 0.02 -0.04 -0.06 -0.07 -0.07 -0.07 -0.05 -0.02 -0.02 0.01 0.04 0.06 0.04 0.06 0.05 0.02 0.02 -0.02 -0.04 -0.039
Sustainable Growth Rate 18.3% 16.8% 17.6% 17.9% 17.3% 17.6% 17.4% 16.4% 16.0% 14.4% 13.0% 12.4% 11.7% 0.3% — — — — — — —
Internal Growth Rate 6.9% 6.7% 7.0% 6.6% 6.4% 7.1% 7.2% 6.8% 6.8% 6.4% 5.9% 5.8% 5.6% 0.1% — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.69 1.95 1.64 1.48 1.41 1.27 1.26 1.29 1.47 1.44 1.61 1.74 1.93 71.34 -24.60 -11.38 -8.98 -5.11 -3.29 -2.44 -2.441
FCF/OCF 0.67 0.70 0.59 0.52 0.46 0.48 0.44 0.46 0.53 0.53 0.59 0.65 0.70 0.68 0.73 0.73 0.73 0.70 0.64 0.64 0.637
FCF/Net Income snapshot only -1.554
OCF/EBITDA snapshot only 2.640
CapEx/Revenue 6.4% 6.5% 7.7% 8.6% 8.8% 8.2% 8.6% 8.0% 7.8% 7.7% 7.1% 6.4% 5.8% 5.8% 5.3% 5.2% 5.1% 5.5% 5.4% 5.3% 5.29%
CapEx/Depreciation snapshot only 0.710
Accruals Ratio -0.04 -0.06 -0.04 -0.03 -0.02 -0.02 -0.02 -0.02 -0.03 -0.03 -0.03 -0.04 -0.05 -0.09 -0.10 -0.11 -0.11 -0.12 -0.10 -0.11 -0.109
Sloan Accruals snapshot only -0.039
Cash Flow Adequacy snapshot only 2.752
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — — — —
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 10.2% 10.4% 9.2% 8.8% 8.9% 7.9% 4.8% 5.0% 5.1% 5.1% 3.3% 4.3% 28.9% 11.6% — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.2% 0.2% 0.3% 0.3% 0.4% 0.3% 0.2% 0.2% 0.2% 0.2% 0.1% 0.2% 1.2% 1.3% 5.9% 6.2% 4.9% 3.6% 2.8% 3.1% 3.10%
Net Buyback Yield 0.2% 0.2% 0.3% 0.3% 0.4% 0.3% 0.1% 0.1% 0.1% 0.1% 0.1% 0.2% 1.2% 1.3% 5.9% 6.2% 4.9% 3.6% 2.7% 3.1% 3.08%
Total Shareholder Return 0.2% 0.2% 0.3% 0.3% 0.4% 0.3% 0.1% 0.1% 0.1% 0.1% 0.1% 0.2% 1.2% 1.3% 5.9% 6.2% 4.9% 3.6% 2.7% 3.1% 3.08%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.81 0.81 0.80 0.82 0.81 0.78 0.77 0.77 0.77 0.82 0.80 0.80 0.80 0.11 -1.05 3.81 3.76 1.45 1.12 1.30 1.298
Interest Burden (EBT/EBIT) 0.84 0.87 0.91 0.93 0.94 0.91 0.88 0.84 0.82 0.81 0.80 0.80 0.80 0.42 0.20 -0.18 -0.25 -13.22 2.78 2.37 2.373
EBIT Margin 0.17 0.16 0.16 0.16 0.15 0.17 0.18 0.18 0.18 0.17 0.17 0.17 0.16 0.05 0.04 0.02 0.02 0.00 -0.01 -0.02 -0.019
Asset Turnover 0.56 0.57 0.56 0.52 0.52 0.54 0.55 0.55 0.56 0.52 0.52 0.52 0.52 0.52 0.51 0.52 0.52 0.55 0.53 0.53 0.530
Equity Multiplier 2.84 2.69 2.69 2.87 2.86 2.65 2.58 2.59 2.53 2.40 2.35 2.25 2.20 2.23 2.30 2.19 2.16 2.21 2.50 2.44 2.437
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $7.69 $7.58 $8.23 $8.65 $8.51 $9.46 $9.65 $9.40 $9.20 $9.19 $8.46 $8.33 $8.01 $0.20 $-0.62 $-1.40 $-1.69 $-2.93 $-3.77 $-4.92 $-4.92
Book Value/Share $47.06 $49.17 $50.86 $51.63 $51.22 $57.93 $60.45 $63.18 $64.06 $69.67 $70.22 $71.80 $73.32 $67.69 $62.82 $68.00 $68.90 $64.30 $60.07 $58.57 $58.70
Tangible Book/Share $-27.34 $-24.02 $-21.54 $-24.28 $-21.78 $-16.13 $-14.61 $-11.56 $-9.01 $-7.02 $-4.97 $-3.03 $-2.34 $-2.12 $-6.58 $-3.76 $-1.78 $1.23 $-7.12 $-10.11 $-10.11
Revenue/Share $66.45 $68.67 $70.72 $71.92 $73.73 $77.39 $79.56 $81.18 $81.69 $79.99 $79.31 $78.65 $78.73 $79.20 $79.10 $81.69 $81.41 $81.59 $82.27 $82.48 $82.48
FCF/Share $8.77 $10.32 $8.03 $6.60 $5.45 $5.74 $5.35 $5.62 $7.14 $7.08 $7.98 $9.39 $10.87 $9.81 $11.08 $11.73 $11.00 $10.54 $7.99 $7.64 $7.64
OCF/Share $12.99 $14.76 $13.51 $12.79 $11.98 $12.06 $12.18 $12.14 $13.52 $13.25 $13.59 $14.46 $15.43 $14.36 $15.27 $15.97 $15.16 $14.99 $12.40 $12.01 $12.01
Cash/Share $4.14 $4.78 $4.73 $4.04 $3.80 $4.55 $3.92 $3.89 $3.05 $5.36 $6.31 $3.46 $4.07 $3.81 $4.51 $3.71 $4.20 $4.34 $3.92 $3.96 $3.96
EBITDA/Share $16.37 $15.91 $16.72 $16.98 $16.99 $19.19 $20.09 $20.41 $20.67 $19.99 $19.46 $19.41 $19.20 $11.36 $10.74 $10.71 $10.45 $8.35 $5.94 $4.55 $4.55
Debt/Share $61.50 $62.18 $58.08 $66.58 $65.37 $60.29 $61.48 $59.85 $56.28 $59.40 $59.38 $54.74 $53.50 $53.27 $58.72 $56.49 $53.24 $62.29 $62.43 $62.44 $62.44
Net Debt/Share $57.36 $57.40 $53.35 $62.54 $61.58 $55.73 $57.56 $55.95 $53.24 $54.04 $53.07 $51.28 $49.42 $49.46 $54.21 $52.79 $49.04 $57.94 $58.52 $58.48 $58.48
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.154
Altman Z-Prime snapshot only 3.212
Piotroski F-Score 5 5 5 6 6 8 7 8 7 5 5 5 6 6 4 5 4 5 3 4 4
Beneish M-Score -2.37 -2.55 -2.39 -2.38 -2.46 -2.40 -2.44 -2.60 -2.55 -2.55 -2.60 -2.63 -2.76 -2.90 -3.01 -3.06 -3.03 -3.15 -2.90 -3.11 -3.111
Ohlson O-Score snapshot only -6.424
Net-Net WC snapshot only $-65.11
EVA snapshot only $-177425240.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB-
Credit Score 69.02 68.47 69.64 58.55 60.41 67.61 64.90 62.78 64.90 66.75 65.60 67.25 61.56 47.10 43.43 41.58 40.93 39.17 28.52 35.90 35.896
Credit Grade snapshot only 13
Credit Trend snapshot only -5.682
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 30
Sector Credit Rank snapshot only 28

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms